EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024

Rhea-AI Summary

EDAP TMS SA (Nasdaq: EDAP) will release its financial results for Q4 and full-year 2023 on March 27, 2024. The company, a leader in robotic energy-based therapies, will host a conference call and webcast with top executives. Details for participation are provided.

Company to host conference call and webcast on Wednesday, March 27^th at 8:30am EDT

LYON, France, March 13, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full-year ended December 31, 2023, before the markets open on Wednesday, March 27^th, 2024.

An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.

Call Details:

Date:	Wednesday, March 27th
Time:	8:30 am EDT
Domestic:	1-877-451-6152
International:	1-201-389-0879
Passcode:	13744102
CallMeTM	LINK (active 15 minutes prior to conference call)
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1653981&tp_key=0c7b100f3f

About EDAP TMS SA

A recognized leader in the global therapeutic ultrasound market. EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and www.focalone.com.

Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com

Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com

 

FAQ

When will EDAP TMS SA release its financial results for Q4 and full-year 2023?

EDAP TMS SA will release its financial results for Q4 and full-year 2023 on March 27, 2024.

Who will be conducting the conference call and webcast for EDAP TMS SA?

The conference call and webcast for EDAP TMS SA will be conducted by Ryan Rhodes (CEO), Ken Mobeck (CFO), and François Dietsch (CAO).

What are the details for participating in the conference call for EDAP TMS SA?

The conference call details are as follows: Date - March 27, 2024, Time - 8:30 am EDT, Domestic number - 1-877-451-6152, International number - 1-201-389-0879, Passcode - 13744102.

Where can one access the webcast for EDAP TMS SA's conference call?

The webcast for EDAP TMS SA's conference call can be accessed at https://viavid.webcasts.com/starthere.jsp?ei=1653981&tp_key=0c7b100f3f.